Delivery Order SPE2DB22D9367-SPE2DB24FSX42

Award Date 4/19/24
Potential Completion Date 4/22/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $11,357.40, was issued by the Defense Logistics Agency's Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the pharmaceutical product NUCALA 100 MG/ML AUTO-INJECTORML, with a performance period ending on April 29, 2024. This award is issued as a delivery order under DMS Pharmaceutical Group's existing indefinite delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,892.90 firm fixed-price delivery order is for the supply of Nucala 100 mg/ml auto-injector medication. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,357.40 firm fixed-price delivery order is for the supply of Nucala 100 mg/mL auto-injectors to support the recurring medical needs of military healthcare facilities. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,892.90 firm fixed-price delivery order is for the supply of Nucala 100 mg/ml auto-injectors to support the recurring medical supply needs of military health facilities worldwide. This award is part of a larger indefinite delivery contract (IDC) vehicle valued at up to $499,999,999 that DMS...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,892.90 firm fixed-price delivery order is for the supply of Nucala 100 mg/mL auto-injectors to support the recurring medical needs of military health facilities worldwide. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA...
This federal contract award, valued at $5,678.70, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of Nucala 100 mg/mL auto-injectors, a specialty medication used to treat certain respiratory conditions. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,973.60 firm fixed price delivery order is for the supply of Nucala 100 mg/mL auto-injectors. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue delivery...
The U.S. government agency, the Defense Logistics Agency (DLA), awarded a firm fixed-price delivery order contract worth $11,357.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of Nucala 100 mg/ml auto-injectors, with a period of performance ending on July 23, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at...
This federal contract award is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $3,785.80, is for the delivery of Nucala 100 mg/mL auto-injectors, a specialized medication. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA, valued at up to $499,999,999, that allows the agency to issue firm...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $18,929.00 firm fixed-price delivery order is for the supply of Nucala 100 mg/mL auto-injectors, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC...
  • SPE2DB22D9367
    Indefinite Delivery Contract
  • SPE2DB22D9367-SPE2DB24FSX42
    Delivery Order

This federal contract award, valued at $11,357.40, was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 100 mg/mL Nucala auto-injector medication.

The award is a delivery order under a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue firm fixed-price orders for a wide range of pharmaceutical products to support the medical supply needs of military health facilities globally. DMS Pharmaceutical Group holds this single-award IDC, which runs through December 31, 2025. The contract does not have a set-aside designation.

Generated 7/19/24, 9:45 AM